The Unified Research Engine for AI
Drug discovery costs $2.6B per approved drug. Takes 10–15 years. Fails 90% of the time. Your AI deserves better data.
122 million enriched compounds. 250,000+ preprints. 500,000+ clinical trials. Pre-computed predictions and regulatory checks—everything your AI needs to think clearly about drug discovery.
Raw databases give you data. They don't tell you if a compound is toxic, controlled, or likely to fail in trials. That insight requires prediction, context, and care.
We've done that work ahead of time. Every molecule in our index carries 84 pre-computed properties—toxicity, drug-likeness, CYP450 interactions, regulatory status across eight jurisdictions. The answers are already waiting.
This isn't about speed for its own sake. It's about removing friction so researchers can stay in flow, moving from question to understanding without interruption.
Anthropic's life sciences connectors give Claude access to raw data. We provide the intelligence layer.
Ask Claude naturally. Get instant molecular intelligence.
"Optimize this lead for better oral bioavailability while maintaining selectivity."
Generate variants, predict ADMET, screen for safety—all in one response.
"Is this molecule safe to develop? Check for regulatory concerns."
Instant screening against DEA, FDA, EPA, CWC, and structural alerts.
"What's known about CDK4/6 inhibitors in breast cancer?"
Search papers, patents, preprints, and clinical trials in one query.
"Find molecules similar to palbociclib with QED > 0.6 and no PAINS."
Filter 122M compounds by similarity, properties, and compliance.
"Predict the structure of this kinase domain."
State-of-the-art protein folding with confidence scores and 3D visualization.
Add NovoMCP to Claude. Works across Claude Desktop, Web, Mobile, and Claude Code (terminal).
Claude recognizes molecular queries and calls the right tools automatically. 22 tools, one interface.
Every response includes automatic safety screening. Lead optimization generates only compliant variants.
Be among the first to experience AI-powered molecular intelligence. Production-ready infrastructure, waiting for design partners who want to shape what comes next.
Become a Design Partner